Infinity Pharmaceuticals | INFI - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
AbbVie USD 4.38B 1.92B 2025-09
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Amgen USD 3.92B 2.35B 2025-09
AstraZeneca USD 3.24B 117M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Cipla INR 11.69B 6.85B 2025-12
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -6.94M 421K 2025-09
CSL USD 2.61B 1.21B 2025-12
Eisai JPY 22B 7.47B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Gilead Sciences USD 3.64B 1.21B 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Grifols EUR 66.98M 19.92M 2024-06
Incyte USD 389.94M 92.37M 2025-12
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
Ionis Pharmaceuticals USD -228M 99M 2025-12
J&J USD 4.97B 2.53B 2025-12
Novartis USD 4.2B 335M 2025-09
Pfizer USD 3.33B 290M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
TG Therapeutics USD 45.09M 19.18M 2025-12